Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

559
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
559
The Bronchial Tree01:23

The Bronchial Tree

7.1K
The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
7.1K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

4.1K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

932
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
932
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

888
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
888
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review.

Journal of medical Internet research·2026
Same author

Neurodevelopmental Profile of Children With MARS1-Related Pulmonary Alveolar Proteinosis: A Cohort Study.

American journal of medical genetics. Part A·2026
Same author

Development and validity evidence for the probabilistic reasoning test in undergraduate medical students.

BMC medical education·2026
Same author

Treatable traits in paediatric bronchiectasis: current practice and a proposed checklist.

European journal of pediatrics·2026
Same author

Reply to "Validation and interpretation of the Pediatric Asthma Treatment Burden Questionnaire: methodological considerations".

The journal of allergy and clinical immunology. In practice·2026
Same author

Two-Year Outcomes in Children Born With a Congenital Pulmonary Malformation.

Pediatrics·2026

Related Experiment Video

Updated: Feb 22, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

Treatable traits in children with bronchiectasis.

Joséphine Annereau1, Apolline Gonsard2, Rola Abou Taam3

  • 1Department of Paediatric Pulmonology and Allergology, AP-HP, University Hospital Necker-Enfants Malades, F-75015 Paris, France; Université Paris Cité, Inria, Inserm, HeKA, F-75015 Paris, France.

Paediatric Respiratory Reviews
|February 20, 2026
PubMed
Summary

The treatable traits (TT) approach identifies modifiable factors in pediatric bronchiectasis. Further research is needed to support these traits specifically in children.

Keywords:
BronchiectasisComorbidityMedication adherencePaediatricsPrecision medicineTraits

More Related Videos

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.5K
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

9.6K

Related Experiment Videos

Last Updated: Feb 22, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.5K
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

9.6K

Area of Science:

  • Pediatric Pulmonology
  • Precision Medicine

Background:

  • Bronchiectasis in children is a complex chronic respiratory condition.
  • Standardized management is crucial, with international guidelines improving consistency.
  • The treatable traits (TT) approach offers a precision-medicine framework.

Purpose of the Study:

  • To identify potential treatable traits (TT) in pediatric bronchiectasis.
  • To assess the evidence base for these TT in children.
  • To guide systematic assessment and future research.

Main Methods:

  • Comprehensive literature review.
  • Identification of potential TT across etiological, pulmonary, extrapulmonary, and behavioral/environmental domains.
  • Assessment of the evidence level for each TT in pediatric populations.

Main Results:

  • Identified 40 potential treatable traits (TT) for pediatric bronchiectasis.
  • Found limited evidence supporting many TT specifically in children.
  • Much of the existing data is extrapolated from adult studies or other respiratory diseases.

Conclusions:

  • The TT approach provides a dynamic framework for individualized assessment in pediatric bronchiectasis.
  • There is an urgent need for pediatric-specific clinical trials to validate these traits.
  • Further research is required to strengthen the evidence base for TT in this population.